Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Labopin

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|June 5, 1998
Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniquesH Firat, M C Giarratana, L Kobari, et al.
Bone Marrow Transplantation|April 12, 2005
Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study groupN Basara, H Baurmann, K Kolbe, et al.
Bone Marrow Transplantation|June 1, 2000
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, N C Gorin, et al.
Leukemia|August 6, 2004
A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplantJ Ph Laporte, M Yeshurun, L Fouillard, et al.
Bone Marrow Transplantation|August 1, 1994
European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT)F Mandelli, M Labopin, A Granena, et al.
European Journal of Haematology|November 1, 1991
Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantationL Marsa-Vila, N C Gorin, J P Laporte, et al.
Leukemia|June 1, 1994
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|October 4, 2019
Hematopoietic cell transplant nurse coordinators' perceptions of related donor care: a European survey from the EBMT Nurses GroupA Polomeni, C Bompoint, M Labopin, et al.
Bone Marrow Transplantation|March 7, 2003
Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrowL Garderet, M Labopin, N C Gorin, et al.
Leukemia & Lymphoma|January 1, 1994
Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromesF Isnard, A Najman, B Jaar, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|June 5, 1998
Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniquesH Firat, M C Giarratana, L Kobari, et al.
Bone Marrow Transplantation|April 12, 2005
Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study groupN Basara, H Baurmann, K Kolbe, et al.
Bone Marrow Transplantation|June 1, 2000
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)O Ringdén, M Labopin, N C Gorin, et al.
Leukemia|August 6, 2004
A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplantJ Ph Laporte, M Yeshurun, L Fouillard, et al.
Bone Marrow Transplantation|August 1, 1994
European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT)F Mandelli, M Labopin, A Granena, et al.
European Journal of Haematology|November 1, 1991
Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantationL Marsa-Vila, N C Gorin, J P Laporte, et al.
Leukemia|June 1, 1994
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|October 4, 2019
Hematopoietic cell transplant nurse coordinators' perceptions of related donor care: a European survey from the EBMT Nurses GroupA Polomeni, C Bompoint, M Labopin, et al.
Bone Marrow Transplantation|March 7, 2003
Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrowL Garderet, M Labopin, N C Gorin, et al.
Leukemia & Lymphoma|January 1, 1994
Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromesF Isnard, A Najman, B Jaar, et al.
Pageof 13